In 1998, I was diagnosed with metastatic melanoma and given months to live. I consulted more than a dozen leading oncologists and got conflicting recommendations. No one could tell me: ‘Which treatment is best for me?’
A clinical trial saved my life—despite itself being unsuccessful—only raising more questions. Why did this therapy work for me but not for others? Could my experience help similar patients? It was life-saving knowledge I wanted to share with all cancer patients.
Welcome to Cancer Commons.
Since our founding in 2011, we have delivered personalized, evidence-based guidance at no charge to more than 10,000 patients and caregivers, supported entirely by philanthropy.
Cancer Commons is staffed by accomplished researchers with PhDs in the molecular biology and pharmacology of cancer and in Artificial Intelligence. They have joined the Commons to apply their knowledge and expertise to help patients research their options in real time using the latest tools of precision oncology.
News & Events
-
NEW Curious Dr. George—How Would a Harvard Oncologist Manage His Own Chronic Lymphocytic Leukemia?
Here’s the latest from our Curious Dr. George! Read “How Would a Harvard Oncologist Manage His Own Chronic Lymphocytic Leukemia?” here. Cancer patients often ask their doctors, “What would you do if you were me?” Here, our Curious Dr. George asks Harvard oncologist Jon Arnason, MD, how he would handle his own diagnosis of chronic lymphocytic leukemia (CLL).
Curious Dr. George: Brad Power, Cancer Hacker—Redesigning the Patient Experience
Here’s the latest from our Curious Dr. George! Read “Brad Power, Cancer Hacker—Redesigning the Patient Experience” here. Brad Power is a cancer survivor, specifically lymphoma, diagnosed in 2018. Since his diagnosis, he has been a particularly engaged patient, advocating for himself to ensure he could make the best possible treatment decisions. Now, through Cancer Patient Lab—an organization he co-founded—he helps other patients do the… Read more »
Curious Dr. George—Raising AI Right: Prioritizing Humanity in Precision Medicine
Here’s the latest from our Curious Dr. George! Read “Raising AI Right: Prioritizing Humanity in Precision Medicine” here. Artificial intelligence (AI) holds promise to transform cancer research and treatment. Here, Curious Dr. George asks our very own Director of Technology, Michael Kramer, about the powerful role Cancer Commons can play in shaping the future of AI in oncology. Having lost his son, Theo, to… Read more »
